9th June 2020 – Nasal Delivery: An Alternative Route

News 9th June 2020 – Nasal Delivery: An Alternative Route As of March 2020, 58% of all therapeutics in development are injectable, 29% oral and 4% inhaled including nasal delivery, and while nasal delivery may not be one of the most explored routes, it holds the potential to offer an alternative delivery method for therapeutics … Read more

12th May 2020 – A Tablet Development Journey at Upperton

News 12th May 2020 – A Tablet Development Journey at Upperton With the continued expansion of our tablet formulation development services, Upperton currently have a number of tablet dosage form development projects completed or in progress. Theses tablet / solid dosage form projects have encompassed a wide range of development activities from Active Pharmaceutical Ingredient … Read more

Upperton Invest £500K in their Tablet Formulation and Manufacturing Capabilities

29th April 2020 – Press Release Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) have invested £500K in significantly expanding their tablet manufacturing capabilities with the addition of tablet processing equipment for wet granulation, roller compaction, tablet compression, hardness testing, dedusting, weight sorting and tablet coating throughout 2019 and 2020. This investment … Read more

Stages of Tablet Development: Compression Equipment Overview

Stages of Tablet Compression Equipment Used During Formulation and Process Development Tablets are one of the most popular dosage forms used in the pharmaceutical, nutraceutical and veterinary industries due to their ease of handling and administration, stability, convenient packing options and well-established cost-effective manufacturing processes which produce consistent quality products. Developing a tablet formulation from … Read more

Formulating Spray Dried Dispersions into Tablets

In this article, Upperton interviewed Dr Ian Lafferty, our Chief Technical Officer on the topic of developing spray dried dispersions (SDDs) into tablets. Ian has 25 years of technical and operational experience in early-phase pharmaceutical development encompassing the formulation design, development, process optimisation and manufacture of a wide range of dosage forms including oral solids … Read more

25th February 2020 – Applications and Techniques of Pharmaceutical Granulation

News 25th February 2020 – Applications and Techniques of Pharmaceutical Granulation Granulation has been widely used in the pharmaceutical industry since the 1950s. Whilst the science remains largely identical to that developed over 70 years ago, granulation techniques and equipment have improved to allow for a greater number of applications in both R&D and manufacture. … Read more

11th February 2020 – Tablets: A General Formulation Overview

News 11th February 2020 – Tablets: A General Formulation Overview Tablets continue to be one of the most popular pharmaceutical dosage forms, as with the right tablet formulation you can achieve: ease of handling and administration for patients, stability convenient packing options, and well-established cost-effective manufacturing processes which produce consistent quality products. However, there are … Read more

28th January 2020 – Tablets: A General Overview

News 28th January 2020 – Tablets: A General Overview Tablets are one of the most popular dosage forms used in the pharmaceutical industry due to their: ease of handling and administration for patients, stability, convenient packing options and well-established cost-effective manufacturing processes which produce consistent quality products. However, there are also disadvantages to presenting a … Read more

14th January 2020 – Oral Solid Dosage Forms Containing Amorphous Spray Dried Dispersions: Choices for First in Human Studies

Oral Solid Dosage Forms Containing Amorphous Spray Dried Dispersions: Choices for First in Human Studies The number of amorphous solid dispersions entering first in human (FIH) studies continues to increase, due to the growing number of novel APIs with a poor solubility profile, and associated bioavailability challenges. Spray drying is a useful technology for creating … Read more

12th December 2019 – Assessing Bioavailability Enabling Technologies using Upperton Pharma Solutions Screening Platform – UpperSolv™+

News 12th December 2019 – Assessing Enabling Technologies using the UpperSolv™+ Screening Platform for Increasing Bioavailability Currently approximately 9 out of 10 new drugs entering clinical trials will fail before reaching approval. Many of these drugs will fail due to problems with ADME (absorption, distribution, metabolism and excretion) rather than lack of efficacy. One of … Read more